David Tabano is a principal health economist and value evidence customer segment lead at Genentech. He leverages HEOR across the Genentech portfolio, developing evidence to support patients' access to care. David joined Genentech in 2020 and has diverse experience in the pharmaceutical industry, as well as in public health, managed care and state Medicaid organizations. David holds bachelors and masters degrees in Economics, and a PhD in Pharmaceutical Outcomes Research.